CXJ GROUP CO., Limited financials

ECXJ CIK 0001823635

Source: EDGAR filings · Built 2026-06-19T00:48:10Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Free Cash Flow -592.97K -383.24K 441.61K
EBITDA -2.25M -1.99M -956.55K -473.98K
Working Capital -1.57M -1.44M -1.62M -1.56M -2.11M -739.09K
Net Debt 26.54K 69.93K -626.86K -751.49K -251.82K -147.45K
Gross Margin 81.25% 70.99% 55.35% 62.55% 61.56% 23.50%
Operating Margin -490.50% -92.04% -49.59% -17.98% -149.81% -84.72%
Net Margin -498.01% -92.11% -49.77% -19.54% -150.59% -89.73%
Return on Equity (ROE) 146.87% -585.85% -42.51% -28.43% -66.52% 114.59%
Return on Assets (ROA) -760.90% -90.69% -19.03% -10.47% -30.93% -20.70%
Current Ratio 0.15× 0.27× 0.47× 0.52× 0.22× 0.82×
Debt-to-Equity -0.02× 0.20× 0.01× 0.04× 0.04× -0.31×
Effective Tax Rate -1.53% -0.24% -0.59% -7.43% -0.52% -0.21%
Cash Conversion Ratio 0.18× 0.28× 0.36× -0.82× -0.07× -0.12×
Accruals Ratio -6.21× -0.66× -0.12× -0.19× -0.33× -0.23×
CapEx Coverage -201.10× -85.53× 231.73×
Free Cash Flow Per Share $-0.01 $-0.00 $0.00

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 458.63K 2.32M
Cost of Revenue 85.97K 672.64K 949.50K 1.04M 403.93K 614.97K
Gross Profit 372.66K 1.65M 1.18M 1.73M 646.90K 188.87K
Research and Development Expense 75.06K
Operating Expenses 2.62M 3.79M
Operating Income (Loss) -2.25M -2.13M -1.05M -498.39K -1.57M -681.05K
Income Tax Expense (Benefit) 34.46K 5.18K 6.24K 37.02K 8.19K 1.42K
Net Income (Loss) Attributable to Parent -2.28M -2.14M -1.06M -541.45K -1.58M -721.29K
Earnings Per Share, Basic $-0.02 $-0.02 $-0.01 $0.00 $-0.02
Weighted Average Number of Shares Outstanding, Basic 102.13M 101.71M 101.71M 101.49M 101.49M
Earnings Per Share, Diluted $-0.02 $-0.02 $-0.01 $0.00 $-0.02
Weighted Average Number of Shares Outstanding, Diluted 102.13M 101.71M 101.71M 101.49M 101.49M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Cash and Cash Equivalents, at Carrying Value 10.04K 2.52K 659.45K 827.14K 340.11K 340.11K
Assets, Current 284.30K 535.30K 1.42M 1.66M 587.89K 3.26M
Assets 300.18K 2.36M 5.56M 5.17M 5.12M 3.49M
Liabilities, Current 1.86M 1.98M 3.04M 3.21M 2.70M 4.00M
Liabilities 1.86M 1.99M 3.05M 3.24M 2.74M 4.11M
Stockholders' Equity Attributable to Parent -1.56M 364.54K 2.49M 1.90M 2.38M -629.46K
Common Stock, Shares, Outstanding 102.27M 101.71M 101.71M 101.49M 101.49M 101.49M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Net Cash Provided by (Used in) Operating Activities -418.52K -590.04K -378.81K 443.52K 103.24K 89.44K
Payments to Acquire Property, Plant, and Equipment 2.93K 4.43K 1.91K
Net Cash Provided by (Used in) Investing Activities -5.74K -1.45M 38 -11.46K -29.65K
Net Cash Provided by (Used in) Financing Activities 423.17K -56.01K 1.71M 77.62K 222.00K -46.51K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (ECXJ CIK 0001823635), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

ICCM

ICECURE MEDICAL LTD.

RXO

RXO, INC.

BCAEF

BCE INC.